TCM
ASLN
Tang Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,901,552
| Closed | -$3.57M | – | 135 |
|
|
2023
Q3 | $3.57M | Buy |
1,901,552
+773,484
| +69% | +$1.45M | 0.5% | 53 |
|
|
2023
Q2 | $4.12M | Sell |
1,128,068
-37,233
| -3% | -$136K | 0.61% | 48 |
|
|
2023
Q1 | $3.36M | Sell |
1,165,301
-4,199,624
| -78% | -$12.1M | 0.5% | 51 |
|
|
2022
Q4 | $1.93M | Sell |
5,364,925
-290,000
| -5% | -$104K | 0.28% | 60 |
|
|
2022
Q3 | $3.39M | Buy |
5,654,925
+100,000
| +2% | +$59.9K | 0.42% | 53 |
|
|
2022
Q2 | $2.75M | Buy |
5,554,925
+2,268,803
| +69% | +$1.12M | 0.42% | 47 |
|
|
2022
Q1 | $2.96M | Buy |
3,286,122
+1,231,197
| +60% | +$1.11M | 0.59% | 37 |
|
|
2021
Q4 | $2.3M | Buy |
2,054,925
+1,079,620
| +111% | +$1.21M | 0.46% | 26 |
|
|
2021
Q3 | $1.74M | Buy |
+975,305
| New | +$1.74M | 0.36% | 20 |
|